Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Close

Johnson & Johnson Co DRC (JNJ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3,999.00 -60.00    -1.48%
03/02 - Closed. Currency in ARS ( Disclaimer )
  • Volume: 4,422
  • Bid/Ask: 3,999.00 / 4,009.50
  • Day's Range: 3,990.00 - 4,100.00
Type:  Equity
Market:  Argentina
ISIN:  ARDEUT110236 
Johnson & Johnson DRC 3,999.00 -60.00 -1.48%

JNJ Financial Summary

 
See below for an overview of the Johnson & Johnson financial reports. To explore the data further, select a tab to navigate onto a specific report page. Choose to view either annual or quarterly report data.

Johnson & Johnson reported earnings results for the third quarter and nine months ended October 02, 2022. For the third quarter, the company reported sales was USD 23,791 million compared to USD 23,338 million a year ago. Net income was USD 4,458 million compared to USD 3,667 million a year ago. Diluted earnings per share from continuing operations was USD 1.68 compared to USD 1.37 a year ago.For the nine months, sales was USD 71,237 million compared to USD 68,971 million a year ago. Net income was USD 14,421 million compared to USD 16,142 million a year ago. Diluted earnings per share from continuing operations was USD 5.41 compared to USD 6.04 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

JNJ Income Statement

Gross margin TTM 67.94%
Operating margin TTM 27.04%
Net Profit margin TTM 18.9%
Return on Investment TTM 20.74%
 Total Revenue  Net Income
Period Ending: Oct 02, 2022 Jul 03, 2022 Apr 03, 2022 Oct 03, 2021
Total Revenue 23791 24020 23426 23338
Gross Profit 15997 16118 15844 16106
Operating Income 6598 6478 6743 6836
Net Income 4458 4814 5149 3667

JNJ Balance Sheet

Quick Ratio MRQ 1.1
Current Ratio MRQ -
LT Debt to Equity MRQ 37%
Total Debt to Equity MRQ 42.93%
 Total Assets  Total Liabilities
Period Ending: Oct 02, 2022 Jul 03, 2022 Apr 03, 2022 Oct 03, 2021
Total Assets 175124 177724 178355
Total Liabilities 100525 101367 103646
Total Equity 74599 76357

JNJ Cash Flow Statement

Cash Flow/Share TTM 8.25
Revenue/Share TTM 36.31
Operating Cash Flow  13.80%
 Cash  Net Change in Cash
Period Ending: Oct 02, 2022 Jul 03, 2022 Apr 03, 2022 Oct 03, 2021
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 6284 5581 3979 8290
Cash From Investing Activities -1701 -2639 -3634 -2719
Cash From Financing Activities -3925 -2261 -4385 -2207
Net Change in Cash 372 520 -4024 3272
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

JNJ Comments

Write your thoughts about Johnson & Johnson Co DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email